Guggenheim Capital’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-55,646
| Closed | -$26K | – | 2997 |
|
|
2016
Q2 | $26K | Buy |
55,646
+2,345
| +4% | +$1.1K | ﹤0.01% | 2794 |
|
|
2016
Q1 | $73K | Buy |
53,301
+16,447
| +45% | +$22.5K | ﹤0.01% | 2781 |
|
|
2015
Q4 | $54K | Buy |
36,854
+1,266
| +4% | +$1.86K | ﹤0.01% | 2889 |
|
|
2015
Q3 | $56K | Sell |
35,588
-774
| -2% | -$1.22K | ﹤0.01% | 2845 |
|
|
2015
Q2 | $62K | Buy |
36,362
+1,837
| +5% | +$3.13K | ﹤0.01% | 2944 |
|
|
2015
Q1 | $48K | Buy |
34,525
+2,600
| +8% | +$3.62K | ﹤0.01% | 2929 |
|
|
2014
Q4 | $48K | Buy |
31,925
+8,299
| +35% | +$12.5K | ﹤0.01% | 2913 |
|
|
2014
Q3 | $48K | Sell |
23,626
-33,994
| -59% | -$69.1K | ﹤0.01% | 2888 |
|
|
2014
Q2 | $177K | Sell |
57,620
-1,805
| -3% | -$5.55K | ﹤0.01% | 2882 |
|
|
2014
Q1 | $148K | Buy |
59,425
+11,393
| +24% | +$28.4K | ﹤0.01% | 2898 |
|
|
2013
Q4 | $238K | Buy |
48,032
+2,128
| +5% | +$10.5K | ﹤0.01% | 2726 |
|
|
2013
Q3 | $105K | Buy |
45,904
+11,084
| +32% | +$25.4K | ﹤0.01% | 2786 |
|
|
2013
Q2 | $78K | Buy |
+34,820
| New | +$78K | ﹤0.01% | 2772 |
|